Average Co-Inventor Count = 6.11
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (43 from 1,970 patents)
2. Abbott Laboratories Corporation (12 from 4,177 patents)
3. University of Pittsburgh (2 from 1,860 patents)
4. Kronos Bio, Inc. (2 from 10 patents)
5. Nura Bio, Inc. (2 from 5 patents)
6. Accent Therapeutics, Inc. (2 from 3 patents)
7. Other (1 from 832,680 patents)
8. Suvalent Therapeutics, Inc. (1 from 2 patents)
9. Amgem Inc. (1 from 1 patent)
66 patents:
1. 12398151 - Sumo inhibitor compounds and uses thereof
2. 12233065 - Inhibitors of RNA helicase DHX9 and uses thereof
3. 12162867 - Inhibitors of RNA helicase DHX9 and uses thereof
4. 12110285 - Substituted pyridine derivatives as SARM1 inhibitors
5. 11845754 - Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
6. 11629136 - Substituted pyridine derivatives as SARM1 inhibitors
7. 11155560 - Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
8. 9394297 - Amides as pim inhibitors
9. 9346801 - Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of use
10. 9321756 - Azole compounds as PIM inhibitors
11. 9187486 - Bicyclic pyridazine compounds as Pim inhibitors
12. 9090593 - Bicyclic compounds as Pim inhibitors
13. 8772481 - Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
14. 8642624 - Substituted alkylamine derivatives and methods of use
15. 8497269 - Phthalazine compounds as p38 map kinase modulators and methods of use thereof